Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Altrubio Inc.

Headquarters: Redwood City, CA, United States of America
Year Founded: 2000
Status: Private

BioCentury | May 23, 2024
Finance

Venture Report: Versant revisits build-to-buy model with obesity play SixPeaks

Plus: Progentos’ launch; series B rounds for AltruBio, Pheon and Grey Wolf; a series A for Vienna-based Ygion; and more
BioCentury | Sep 15, 2021
Management Tracks

Skullerud named CEO at Nordic Nanovector

Plus: Pyxis, ViaCyte, Neogene, AltruBio, Lyra and more
BioCentury | Aug 10, 2021
Management Tracks

Bogle replaces Bazemore as CEO at Epizyme

Plus: Updates from AltruBio, Sutro, Rheos, Affinivax and more
BioCentury | Apr 16, 2021
Finance

April 15 Quick Takes: Co-founded by Springer and Kruse, GPCR play Tectonic raises $80M; plus AltruBio, Rapha, Benchling, BioAge, Amgen

Tectonic Therapeutic Inc. debuted with an $80 million series A round co-led by Vida Ventures, T.A. Springer, and Polaris Partners to discover and develop of GPCR-targeted therapies. Tectonic was
Items per page:
1 - 4 of 4